Insulet (PODD) Income towards Parent Company (2010 - 2026)
Insulet posted quarterly Income towards Parent Company of $91.1 million for Q1 2026, up 156.62% year-on-year from $35.5 million in Q1 2025, and down 10.42% on a QoQ basis from $101.7 million in Q4 2025.
Insulet (PODD) has 16 years of Income towards Parent Company data on file, last reported at $91.1 million in Q1 2026.
- For the quarter ending Q1 2026, Income towards Parent Company rose 156.62% year-over-year to $91.1 million; the trailing twelve-month figure through Mar 2026 stood at $302.9 million (down 24.71% YoY), and the FY2025 full-year result was $247.1 million, down 40.93% from the prior year.
- Income towards Parent Company for Q1 2026 stood at $91.1 million, down from $101.7 million in the prior quarter.
- Across five years, Income towards Parent Company topped out at $188.6 million in Q2 2024 and bottomed at -$35.0 million in Q2 2022.
- The 5-year median for Income towards Parent Company is $51.5 million (2024), against an average of $56.9 million.
- The widest annual swing landed in 2022, when Income towards Parent Company slumped 141.27%; it then surged 1098.08% in 2023.
- A 5-year view of Income towards Parent Company shows it stood at $17.0 million in 2022, then surged by 508.24% to $103.4 million in 2023, then decreased by 2.61% to $100.7 million in 2024, then climbed by 0.99% to $101.7 million in 2025, then slipped by 10.42% to $91.1 million in 2026.
- The last three Income towards Parent Company figures came in at $91.1 million (Q1 2026), $101.7 million (Q4 2025), and $87.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Insulet | 10.37 Bn | 9.89 Bn | 529.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91.10 Mn |
| Dec 31, 2025 | 101.70 Mn |
| Sep 30, 2025 | 87.60 Mn |
| Jun 30, 2025 | 22.50 Mn |
| Mar 31, 2025 | 35.50 Mn |
| Dec 31, 2024 | 100.70 Mn |
| Sep 30, 2024 | 77.50 Mn |
| Jun 30, 2024 | 188.60 Mn |
| Mar 31, 2024 | 51.50 Mn |
| Dec 31, 2023 | 103.40 Mn |
| Sep 30, 2023 | 51.90 Mn |
| Jun 30, 2023 | 27.30 Mn |
| Mar 31, 2023 | 23.80 Mn |
| Dec 31, 2022 | 17.00 Mn |
| Sep 30, 2022 | -5.20 Mn |
| Jun 30, 2022 | -35.00 Mn |
| Mar 31, 2022 | 27.80 Mn |
| Dec 31, 2021 | 29.20 Mn |
| Sep 30, 2021 | 12.60 Mn |
| Jun 30, 2021 | -25.00 Mn |
| Dec 31, 2020 | -17.10 Mn |
| Sep 30, 2020 | 11.60 Mn |
| Jun 30, 2020 | 14.40 Mn |
| Mar 31, 2020 | -2.10 Mn |
| Dec 31, 2019 | 5.00 Mn |
| Sep 30, 2019 | 800,000.00 |
| Jun 30, 2019 | 1.40 Mn |
| Mar 31, 2019 | 4.40 Mn |
| Dec 31, 2018 | 9.90 Mn |
| Sep 30, 2018 | 1.66 Mn |
| Jun 30, 2018 | -1.69 Mn |
| Mar 31, 2018 | -6.54 Mn |
| Dec 31, 2016 | 34,000.00 |
| Sep 30, 2016 | -64,000.00 |
| Jun 30, 2016 | 153,000.00 |
| Mar 31, 2016 | -1.79 Mn |
| Dec 31, 2015 | -11.42 Mn |
| Sep 30, 2015 | -943,000.00 |
| Jun 30, 2015 | 1.84 Mn |
| Mar 31, 2015 | -1.39 Mn |
| Dec 31, 2014 | -1.84 Mn |
| Sep 30, 2014 | -10.85 Mn |
| Jun 30, 2014 | -29.11 Mn |
| Mar 31, 2014 | -6.14 Mn |
| Dec 31, 2013 | -2.50 Mn |
| Sep 30, 2013 | -21.29 Mn |
| Jun 30, 2013 | -10.52 Mn |
| Mar 31, 2013 | -10.67 Mn |
| Dec 31, 2012 | -10.19 Mn |
| Sep 30, 2012 | -12.42 Mn |
| Jun 30, 2012 | -14.48 Mn |
| Mar 31, 2012 | -14.78 Mn |
| Dec 31, 2011 | -14.34 Mn |
| Sep 30, 2011 | -13.56 Mn |
| Jun 30, 2011 | -8.08 Mn |
| Mar 31, 2011 | -9.85 Mn |
| Dec 31, 2010 | -20.86 Mn |
| Sep 30, 2010 | -12.10 Mn |
| Jun 30, 2010 | -13.71 Mn |